POLYMORPH OF GRANATICIN B

The present invention provides a crystalline Form A of Compound 1, also referred to as Granaticin B, and pharmaceutically compositions thereof. The present invention also provides methods of treating a microbial infection, or a disease, disorder, or condition associated with abnormal cellular prolif...

Full description

Saved in:
Bibliographic Details
Main Author KUNNARI, TERO
Format Patent
LanguageEnglish
French
Published 09.05.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides a crystalline Form A of Compound 1, also referred to as Granaticin B, and pharmaceutically compositions thereof. The present invention also provides methods of treating a microbial infection, or a disease, disorder, or condition associated with abnormal cellular proliferation, using crystalline Form A of Compound 1 or pharmaceutical compositions thereof. La présente invention concerne une forme cristalline A d'un composé 1, dénommé également granaticine B, et des compositions pharmaceutiques de celle-ci. La présente invention concerne également des méthodes de traitement d'une infection microbienne ou d'une maladie, d'un trouble ou d'un état pathologique associés à une prolifération cellulaire anormale, faisant appel à la forme cristalline A du composé 1 ou à des compositions pharmaceutiques de celle-ci.
Bibliography:Application Number: CA20152972266